2025-04-23 - Analysis Report
## Microstrategy Inc. (MSTR) Stock Review

**0. Key Figures & Initial Analysis:**

MSTR, Microstrategy Inc., is a publicly traded business intelligence company.  The provided data shows significant outperformance compared to the S&P 500 (VOO).

**1. Performance Comparison & Divergence:**

* **MSTR Cumulative Return:** 1159.67%
* **VOO Cumulative Return:** 76.31%
* **Return Difference:** 1083.36% (MSTR significantly outperforms VOO)
* **Relative Divergence:** 56.6% (This indicates MSTR's performance is in the upper 56.6th percentile of its historical performance relative to the S&P 500.)  The high relative divergence, despite volatility, highlights MSTR's substantial outperformance.  The alpha and beta values in the table below show a volatile relationship with the market.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -25.0% | 56.6% | -57.0% | -0.1 | 3.3 |
| 2016-2018  | -21.0% | 62.6% | -42.0% | -0.2 | 3.2 |
| 2017-2019  | -23.0% | 62.6% | -57.0% | -0.4 | 3.6 |
| 2018-2020  | 135.0% | 62.6% | 105.0% | -0.6 | 9.7 |
| 2019-2021  | 170.0% | 71.0% | 110.0% | -0.6 | 13.6 |
| 2020-2022  | 16.0% | 72.7% | 7.0% | -0.0 | 3.5 |
| 2021-2023  | 9.0% | 72.7% | -12.0% | 3.3 | 15.7 |
| 2022-2024  | 1382.0% | 72.7% | 1362.0% | 3.4 | 72.2 |
| 2023-2025  | 1088.0% | 66.5% | 1074.0% | 1.0 | 85.5 |


**2. Recent Price Movement:**

* **Closing Price:** $343.03
* **5-Day Moving Average:** $320.07
* **20-Day Moving Average:** $302.75
* **60-Day Moving Average:** $303.74

The price is significantly above its 5, 20, and 60-day moving averages, suggesting a recent strong upward trend. The Last-market data shows a considerable daily increase of 7.95, indicating a sharp upward movement.

**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.435 (Low to Medium Risk)
* **RSI:** 57.14 (Slightly above neutral; not overbought)
* **PPO:** 1.76 (Positive; suggests upward momentum)
* **20-Day Relative Divergence Change:** +5.3 (Short-term upward trend)
* **Expected Return (2+ years):** 129.3% (Significant outperformance of the S&P 500 expected over the long term)

The combination of indicators suggests a bullish outlook. The sharp price increase indicated by `Last-market` reinforces this.

**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue     |
|------------|--------|-------------|
| 2024-10-31 | -$1.72 | $0.12B      |
| 2024-08-06 | -$5.74 | $0.11B      |
| 2024-05-01 | -$3.09 | $0.12B      |
| 2023-11-01 | -$10.09| $0.13B      |
| 2024-10-31 | -$1.01 | $0.13B      |


The company has reported consistent losses over the provided period.  Revenue remains relatively stable, but the negative EPS figures are concerning and require further investigation into the underlying causes.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.12B | 71.69% |
| 2024-09-30 | $0.12B | 70.41% |
| 2024-06-30 | $0.11B | 72.24% |
| 2024-03-31 | $0.12B | 73.96% |
| 2023-12-31 | $0.12B | 77.33% |

**Capital and Profitability:**

| Quarter | Equity    | ROE      |
|---------|-----------|----------|
| 2024-12-31 | $18.23B  | -3.68%   |
| 2024-09-30 | $3.77B   | -9.01%   |
| 2024-06-30 | $2.83B   | -3.62%   |
| 2024-03-31 | $2.40B   | -2.21%   |
| 2023-12-31 | $2.16B   | 4.12%    |

High profit margins are observed despite negative EPS and ROE in recent quarters, suggesting a need for deeper analysis of the company's accounting practices and financial health. The significant fluctuation in equity is also noteworthy.


**6. Overall Analysis:**

MSTR exhibits a strong historical outperformance compared to the S&P 500.  Recent price action shows a sharp upward trend, supported by positive technical indicators.  However, the company's consistently negative EPS and fluctuating ROE raise significant concerns regarding its fundamental financial health.  The high profit margins are counterintuitive to the negative EPS.  Further investigation is needed to understand the discrepancy between the strong price performance and the negative earnings.  A deep dive into the company's financial statements and business model is crucial before making any investment decisions. The high expected return should be viewed with caution given the fundamental weaknesses.  It is essential to understand why MSTR is outperforming the market so drastically before committing capital.
